- United Kingdom
- /
- Food
- /
- AIM:DKL
When Will Dekel Agri-Vision plc (LON:DKL) Breakeven?
We feel now is a pretty good time to analyse Dekel Agri-Vision plc's (LON:DKL) business as it appears the company may be on the cusp of a considerable accomplishment. Dekel Agri-Vision plc, through its subsidiaries, develops and cultivates palm oil plantations in the Republic of Cote d’Ivoire. On 31 December 2024, the UK£6.6m market-cap company posted a loss of €3.5m for its most recent financial year. As path to profitability is the topic on Dekel Agri-Vision's investors mind, we've decided to gauge market sentiment. We've put together a brief outline of industry analyst expectations for the company, its year of breakeven and its implied growth rate.
According to some industry analysts covering Dekel Agri-Vision, breakeven is near. They expect the company to post a final loss in 2025, before turning a profit of €500k in 2026. So, the company is predicted to breakeven just over a year from now. What rate will the company have to grow year-on-year in order to breakeven on this date? Using a line of best fit, we calculated an average annual growth rate of 113%, which is rather optimistic! If this rate turns out to be too aggressive, the company may become profitable much later than analysts predict.
Given this is a high-level overview, we won’t go into details of Dekel Agri-Vision's upcoming projects, however, keep in mind that by and large a high growth rate is not out of the ordinary, particularly when a company is in a period of investment.
See our latest analysis for Dekel Agri-Vision
One thing we would like to bring into light with Dekel Agri-Vision is its debt-to-equity ratio of over 2x. Generally, the rule of thumb is debt shouldn’t exceed 40% of your equity, which in this case, the company has significantly overshot. A higher level of debt requires more stringent capital management which increases the risk around investing in the loss-making company.
Next Steps:
This article is not intended to be a comprehensive analysis on Dekel Agri-Vision, so if you are interested in understanding the company at a deeper level, take a look at Dekel Agri-Vision's company page on Simply Wall St. We've also put together a list of essential aspects you should look at:
- Valuation: What is Dekel Agri-Vision worth today? Has the future growth potential already been factored into the price? The intrinsic value infographic in our free research report helps visualize whether Dekel Agri-Vision is currently mispriced by the market.
- Management Team: An experienced management team on the helm increases our confidence in the business – take a look at who sits on Dekel Agri-Vision’s board and the CEO’s background.
- Other High-Performing Stocks: Are there other stocks that provide better prospects with proven track records? Explore our free list of these great stocks here.
New: Manage All Your Stock Portfolios in One Place
We've created the ultimate portfolio companion for stock investors, and it's free.
• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About AIM:DKL
Dekel Agri-Vision
Through its subsidiaries, develops and cultivates palm oil plantations in the Republic of Cote d’Ivoire.
Undervalued with slight risk.
Similar Companies
Market Insights
Weekly Picks

Cue Biopharma (NASDAQ: CUE): The Scientist Behind Xolair Just Gave Cue a Next-Generation Shot at the Same Multi-Billion-Dollar Market

AST SpaceMobile: The Boldest Direct-to-Cell Bet in Public Markets
Onto Innovation: The Advanced Packaging Chokepoint 51.3% undervalued intrinsic discount

Investment Analysis (May 2026)
Recently Updated Narratives
Vusion's Profit Margin to Grow by 9.74% Promises Bright Future
Deep Value Multi Bagger Opportunity

Mobile strategy pays off as churn falls
Popular Narratives
QuantumScape: A Mispriced Deep‑Tech Inflection Point With Multi‑Billion‑Dollar Optionality

Take-Two Interactive: The Calm Before the Storm NASDAQ: TTWO Last Price: $242.41 Date: May 15, 2026
